MRKR Earnings

Quarterly EPS
$-0.26
Q3 2024
$-0.42
Q4 2024
$-0.40
Q1 2025
$-0.29
Q2 2025
$-0.12
Q3 2025
$-0.09
Q4 2025
$-0.16
Q1 2026
$-0.09
Q2 2026
Latest RevenueN/A
Latest Net Income-1826229
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.090-1826229+69.0%
Q1 2026-$0.160-3179278+60.0%
Q4 2025-$0.091.1M-1703210-51.0%+78.6%
Q3 2025-$0.121.2M-1998662-36.0%+53.8%
Q2 2025-$0.290-4015564-100.0%-16.0%
Q1 2025-$0.400-4446184-100.0%-48.1%
Q4 2024-$0.422.3M-3837624+113.1%-31.2%
Q3 2024-$0.261.9M-2308192+647.7%+23.5%
Q2 2024-$0.251.2M-2192677
Q1 2024-$0.271.2M-2392822
Q4 2023-$0.321.1M-2803066
Q3 2023-$0.34257.6K-2981961
Marker Therapeutics (MRKR) — Earnings